The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience

Detalles Bibliográficos
Autores principales: Rush, Cassandra, Faulk, Kelly E., Bradley, Zanette Kanani, Turner, Aubree, Krumins, Maija, Greenhawt, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Clinical Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648374/
https://www.ncbi.nlm.nih.gov/pubmed/34883262
http://dx.doi.org/10.1016/j.jaip.2021.11.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648374/
https://www.ncbi.nlm.nih.gov/pubmed/34883262
http://dx.doi.org/10.1016/j.jaip.2021.11.025

Ejemplares similares